Universal Health Services (UHS) FY2025 results: revenue $17.4 billion, up 9.7% on the year
Universal Health Services Inc. (UHS) reported revenue of $17.4 billion for fiscal 2025, the year ended 31 December 2025, up 9.7% on the year before. Net income was $1.5 billion, up 30.4%, and diluted earnings per share $23.10. The figures are the company's own, from the 10-K it filed with the SEC on 25 February 2026.
this yearthe year beforeHover a bar for its figure.
The year in brief
What management said about the year
Guidance figures: 11 new.
- Fourth-quarter net income rose: Fourth-quarter net income attributable to UHS was $445.9 million, or $7.06 per diluted share, against $332.4 million, or $4.96, a year earlier. Net revenues rose 9.1% to $4.486 billion, from $4.114 billion.
- Generative AI stake gain in reported results: Reported results included an unrealized after-tax gain on a minority stake in a healthcare generative AI company, recorded in other (income) expense, net. Adjusted results exclude this gain.
- Full-year net income and revenue: Full-year 2025 net income attributable to UHS was $1.489 billion, or $23.10 per diluted share, against $1.142 billion, or $16.82. Net revenues rose 9.7% to $17.365 billion.
- Acute same-facility revenue up 8.5%: Same-facility acute care revenues rose 8.5% in 2025 and 6.9% in the fourth quarter. Adjusted admissions rose 1.6% for the year and were unchanged in the quarter; adjusted patient days rose 0.3% for the year and fell 0.7% in the quarter.
- Acute pricing drove quarter growth: In the fourth quarter, same-facility acute revenue per adjusted admission rose 5.4% and per adjusted patient day rose 6.1%, while adjusted admissions were unchanged and adjusted patient days fell 0.7%.
From this 10-K
Universal Health Services owns and operates, through subsidiaries, acute care hospitals, outpatient facilities and behavioral health care facilities. As of 25 February 2026 it owned or operated 375 inpatient facilities and 168 outpatient and other facilities in 40 states, Washington, D.C., the United Kingdom and Puerto Rico. It is a Delaware corporation organised in 1979 and based in King of Prussia, Pennsylvania.
The four quarters: Q1 FY2025 · Q2 FY2025 · Q3 FY2025 · Q4 FY2025
Income statement (profit and loss)
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Revenue | 17,365 | 15,828 | 14,282 | +9.7% | |
| Operating income | 1,994 | 1,682 | 1,175 | +18.6% | |
| Operating margin | 11.5% | 10.6% | 8.2% | ||
| Interest expense | 156 | 186 | 207 | -16.1% | |
| Pre-tax income | 1,972 | 1,498 | 940 | +31.7% | |
| Income tax | 461 | 335 | 221 | +37.7% | |
| Effective tax rate | 23.4% | 22.4% | 23.5% | ||
| Net income | 1,489 | 1,142 | 718 | +30.4% | |
| Net margin | 8.6% | 7.2% | 5.0% | ||
| Diluted EPS | $23.10 | $16.82 | $10.23 | +37.3% |
Read more
Free cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.Cash flow
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Operating cash flow | 1,864 | 2,067 | 1,268 | -9.8% | |
| Capital expenditure | 1,015 | 944 | 743 | +7.6% | |
| Free cash flow | 849 | 1,123 | 525 | -24.4% | |
| Free cash flow margin | 4.9% | 7.1% | 3.7% | ||
| Cash from investing | -1,071 | -911 | -763 | ||
| Cash from financing | -750 | -1,145 | -494 | ||
| Depreciation and amortisation | 619 | 585 | 568 | +5.8% | |
| Share-based compensation | 95.7 | 99.3 | 87.7 | -3.7% | |
| Buybacks | 968 | 671 | 547 | +44.3% | |
| Dividends paid | 51.3 | 53.3 | 55.5 | -3.9% | |
| Dividend per share | $0.80 | $0.80 | $0.80 | 0.0% | |
| Diluted shares, weighted | 64m | 68m | 70m | -5.1% |
Balance sheet
| $ million | FY2025 | FY2024 | FY2023 | On the year | Last 8 years |
|---|---|---|---|---|---|
| Shareholders' equity | 7,276 | 6,666 | 6,149 | +9.1% | |
| Non-controlling interest | 63.0 | 83.3 | 47.7 | -24.4% | |
| Redeemable equity | 70.6 | 13.3 | 5.2 | +431.3% | |
| Debt | 4,753 | 4,505 | 4,912 | +5.5% | |
| Operating lease liabilities | 341 | 376 | 383 | -9.4% | |
| Finance lease liabilities | 85.4 | 87.2 | 69.6 | -2.1% | |
| Other liabilities | 2,940 | 2,739 | 2,401 | +7.3% | |
| Total liabilities and equity | 15,528 | 14,470 | 13,968 | +7.3% | |
| Fixed assets | 7,008 | 6,572 | 6,125 | +6.6% | |
| Goodwill | 3,990 | 3,933 | 3,932 | +1.5% | |
| Intangible assets | 75.9 | 76.3 | 77.0 | -0.5% | |
| Cash and equivalents | 138 | 126 | 119 | +9.4% | |
| Receivables | 2,602 | 2,178 | 2,238 | +19.5% | |
| Other assets | 1,713 | 1,585 | 1,476 | +8.1% | |
| Total assets | 15,528 | 14,470 | 13,968 | +7.3% |
10-K for the year ended 31 December 2025, filed 25 February 2026: the filing.